Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status

• Published in: Journal of personalized medicine 2023-01, Vol.13 (2), p.245
• Main Authors: Cao, Xiaoying, He, Jiaming, Chen, An, Ran, Jianhua, Li, Jing, Chen, Dilong, Zhang, Hengshu
• Format: Article
• Language: English
• Subjects: Algorithms; Analysis; Antibodies; Apoptosis; Cancer; Drug development; Gene expression; Gene set enrichment analysis; Genes; Genetic aspects; Genomes; Genotypes; Immune system; Immunohistochemistry; Immunosuppressive agents; Immunotherapy; Medical prognosis; Melanoma; Metastases; Microenvironments; Mutation; Necroptosis; Polo-like kinase 1; Precision medicine; Prognosis; Risk groups; Signal transduction; Skin; Skin cancer; Tumors
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm13020245

Due to poor prognosis and immunotherapy failure of skin cutaneous melanoma (SKCM), this study sought to find necroptosis-related biomarkers to predict prognosis and improve the situation with predicted immunotherapy drugs. The Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression Program (GTEx) database were utilized to recognize the differential necroptosis-related genes (NRGs). Univariate Cox (uni-Cox) and least absolute shrinkage and selection operator (LASSO) Cox analysis were utilized for prognostic signature establishment. The signature was verified in the internal cohort. To assess the signature's prediction performance, the area under the curve (AUC) of receiver operating characteristic (ROC) curves, Kaplan-Meier (K-M) analyses, multivariate Cox (multi-Cox) regression, nomogram, and calibration curves were performed. The molecular and immunological aspects were also reviewed using single-sample gene set enrichment analysis (ssGSEA). Cluster analysis was performed to identify the different types of SKCM. Finally, the expression of the signature gene was verified by immunohistochemical staining. On basis of the 67 NRGs, 4 necroptosis-related genes (FASLG, PLK1, EGFR, and TNFRSF21) were constructed to predict SKCM prognosis. The area's 1-, 3-, and 5-year OS under the AUC curve was 0.673, 0.649, and 0.677, respectively. High-risk individuals had significantly lower overall survival (OS) compared to low-risk patients. Immunological status and tumor cell infiltration in high-risk groups were significantly lower, indicating an immune system that was suppressed. In addition, hot and cold tumors could be obtained by cluster analysis, which is helpful for accurate treatment. Cluster 1 was considered a hot tumor and more susceptible to immunotherapy. Immunohistochemical results were consistent with positive and negative regulation of coefficients in signature. The results of this finding supported that NRGs could predict prognosis and help make a distinction between the cold and hot tumors for improving personalized therapy for SKCM.